1,000
Views
10
CrossRef citations to date
0
Altmetric
Laboratory Study

DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population

, &

Figures & data

Figure 1. XPD 312 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 2 and 7 are homozygous Asp/Asp genotype. Lanes 3, 4, 5 and 9 are heterozygous Asp/Asn genotype. Lane 6 is homozygous Asn/Asn genotype. Lane 8 is 100 bp ladder.

Figure 1. XPD 312 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 2 and 7 are homozygous Asp/Asp genotype. Lanes 3, 4, 5 and 9 are heterozygous Asp/Asn genotype. Lane 6 is homozygous Asn/Asn genotype. Lane 8 is 100 bp ladder.

Figure 2. XPD 751 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 6 and 9 are homozygous Lys/Lys genotype. Lanes 2 and 4 are heterozygous Lys/Gln genotype. Lanes 3, 5, 7 and 10 are homozygous Gln/Gln genotype. Lane 8 is 100 bp ladder.

Figure 2. XPD 751 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 6 and 9 are homozygous Lys/Lys genotype. Lanes 2 and 4 are heterozygous Lys/Gln genotype. Lanes 3, 5, 7 and 10 are homozygous Gln/Gln genotype. Lane 8 is 100 bp ladder.

Figure 3. XRCC1 399 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 4, 5, 7 and 11 are homozygous Arg/Arg genotype. Lanes 2, 3, 6 and 10 are heterozygous Arg/Gln genotype. Lane 9 is homozygous Gln/Gln genotype. Lane 8 is 100 bp ladder.

Figure 3. XRCC1 399 genotypes on ethidium bromide stained 3% agarose gel. Lanes 1, 4, 5, 7 and 11 are homozygous Arg/Arg genotype. Lanes 2, 3, 6 and 10 are heterozygous Arg/Gln genotype. Lane 9 is homozygous Gln/Gln genotype. Lane 8 is 100 bp ladder.

Table 1. Distribution of XPD and XRCC1 genotype polymorphisms in patients and controls.

Table 2. Distribution of combined XPD and XRCC1 genotypes among ESRD patients and control.

Table 3. Haplotype association of XPD 312 and XRCC1 399 with ESRD.

Table 4. Haplotype association of XPD 751 and XRCC1 399 with ESRD.

Table 5. Haplotype association of XPD 312, XPD 751 and XRCC1 399 with ESRD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.